Andrew J. Last Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew J. Last.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew J. Last. Andrew J. Last is EVP, Chief Operating Officer in BIO-RAD LABORATORIES, INC. ($BIO) and Chief Commercial Officer in AFFYMETRIX INC ($AFFX) and EVP and GM, GABU in AFFYMETRIX INC ($AFFX) and EVP, Chief Operating Officer in AFFYMETRIX INC ($AFFX) and Chief Operating Officer in INTREXON CORP ($XON) and Director in OncoCyte Corp ($OCX).
Latest Insider Trading Transactions of Andrew J. Last
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AFFX, BIO, OCX, XON
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | X | 3.00 | 6,993 | 20,979 | 0 | |
Jun 14 2021 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | X | 3.00 | 6,993 | 20,979 | 30,170 | 23.2 K to 30.2 K (+30.17 %) |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,000 | 0 | 3,000 | |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 640.73 | 466 | 298,580 | 1,268 | 1.7 K to 1.3 K (-26.87 %) |
Apr 30 2021 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,000 | 0 | 1,734 | 734 to 1.7 K (+136.24 %) |
Dec 15 2020 | OCX | OncoCyte Corp | Last Andrew J. | Director | Grant | A | 0.00 | 16,184 | 0 | 23,177 | 7 K to 23.2 K (+231.43 %) |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 524.30 | 3,610 | 1,892,723 | 3,610 | |
Sep 04 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 3,610 | 0 | 3,610 | |
Jun 19 2020 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.38 | 57,000 | 135,660 | 57,000 | |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 0.00 | 1,000 | 0 | 4,000 | |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 436.27 | 346 | 150,949 | 680 | 1 K to 680 (-33.72 %) |
Apr 30 2020 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 0.00 | 1,000 | 0 | 1,026 | 26 to 1 K (+3,846.15 %) |
Jul 19 2019 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.12 | 45,000 | 95,400 | 45,000 | |
Jul 19 2019 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.12 | 45,000 | 95,400 | 45,000 | |
Apr 30 2019 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 299.24 | 5,000 | 1,496,200 | 5,000 | |
Apr 30 2019 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Sep 04 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 2.40 | 45,000 | 108,000 | 45,000 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | P | 3.00 | 6,993 | 20,979 | 6,993 | |
Jul 31 2018 | OCX | OncoCyte Corp | Last Andrew J. | Director | Buy | P | 0.00 | 6,993 | 0 | 6,993 | 0 to 7 K |
Nov 15 2017 | XON | INTREXON CORP | Last Andrew J. | Chief Operating Off ... | Buy | P | 12.10 | 2,000 | 24,200 | 4,000 | 2 K to 4 K (+100.00 %) |
Aug 15 2017 | XON | INTREXON CORP | Last Andrew J. | Chief Operating Off ... | Buy | P | 19.99 | 2,000 | 39,980 | 2,000 | 0 to 2 K |
Jun 20 2017 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 5.10 | 20,000 | 102,000 | 20,000 | |
Jun 20 2017 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 5.10 | 6,520 | 33,252 | 6,520 | |
Aug 31 2016 | XON | INTREXON CORP | Last Andrew J. | Chief Operating Off ... | Option Exercise | A | 25.47 | 600,000 | 15,282,000 | 600,000 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 0.00 | 35,817 | 0 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 11.88 | 31,300 | 371,844 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 7.55 | 35,000 | 264,250 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 3.84 | 50,000 | 192,000 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 4.85 | 60,000 | 291,000 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 5.31 | 51,000 | 270,810 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | D | 4.22 | 50,000 | 211,000 | 0 | |
Apr 01 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Sell | D | 0.00 | 223,548 | 0 | 0 | 223.5 K to 0 (-100.00 %) |
Feb 18 2016 | OCX | OncoCyte Corp | Last Andrew J. | Director | Option Exercise | A | 3.06 | 20,000 | 61,200 | 20,000 | |
Feb 25 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 14.06 | 940 | 13,216 | 223,548 | 224.5 K to 223.5 K (-0.42 %) |
Feb 22 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 13.98 | 1,598 | 22,340 | 224,488 | 226.1 K to 224.5 K (-0.71 %) |
Feb 22 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 13.98 | 4,673 | 65,329 | 226,086 | 230.8 K to 226.1 K (-2.03 %) |
Feb 22 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 35,817 | 0 | 230,759 | 194.9 K to 230.8 K (+18.37 %) |
Feb 17 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 14.09 | 2,819 | 39,720 | 194,942 | 197.8 K to 194.9 K (-1.43 %) |
Feb 17 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 14.09 | 2,182 | 30,744 | 197,761 | 199.9 K to 197.8 K (-1.09 %) |
Feb 17 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 14.09 | 7,466 | 105,196 | 199,943 | 207.4 K to 199.9 K (-3.60 %) |
Feb 10 2016 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 37,297 | 0 | 207,409 | 170.1 K to 207.4 K (+21.92 %) |
Mar 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 4.22 | 20,000 | 84,400 | 50,000 | |
Mar 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | M | 5.29 | 90,000 | 476,100 | 0 | |
Mar 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Sell | S | 12.79 | 110,000 | 1,406,900 | 170,112 | 280.1 K to 170.1 K (-39.27 %) |
Mar 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 4.22 | 20,000 | 84,400 | 280,112 | 260.1 K to 280.1 K (+7.69 %) |
Mar 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Buy | M | 5.29 | 90,000 | 476,100 | 260,112 | 170.1 K to 260.1 K (+52.91 %) |
Feb 26 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 11.64 | 5,638 | 65,626 | 170,112 | 175.8 K to 170.1 K (-3.21 %) |
Feb 19 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 11.88 | 31,300 | 371,844 | 31,300 | |
Feb 19 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 17,000 | 0 | 175,750 | 158.8 K to 175.8 K (+10.71 %) |
Feb 18 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 11.77 | 940 | 11,064 | 158,750 | 159.7 K to 158.8 K (-0.59 %) |
Feb 18 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 11.45 | 2,837 | 32,484 | 159,690 | 162.5 K to 159.7 K (-1.75 %) |
Feb 18 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 11.45 | 2,190 | 25,076 | 162,527 | 164.7 K to 162.5 K (-1.33 %) |
Feb 18 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 11.45 | 7,509 | 85,978 | 164,717 | 172.2 K to 164.7 K (-4.36 %) |
Feb 04 2015 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 40,000 | 0 | 172,226 | 132.2 K to 172.2 K (+30.25 %) |
Aug 21 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 8.73 | 1,410 | 12,309 | 132,226 | 133.6 K to 132.2 K (-1.06 %) |
Feb 27 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 7.47 | 5,554 | 41,488 | 133,636 | 139.2 K to 133.6 K (-3.99 %) |
Feb 19 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 7.28 | 1,078 | 7,848 | 139,190 | 140.3 K to 139.2 K (-0.77 %) |
Feb 19 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Payment of Exercise | F | 7.28 | 3,291 | 23,958 | 140,268 | 143.6 K to 140.3 K (-2.29 %) |
Feb 13 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 7.55 | 35,000 | 264,250 | 35,000 | |
Feb 13 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 20,000 | 0 | 143,559 | 123.6 K to 143.6 K (+16.19 %) |
Feb 13 2014 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP, Chief Operatin ... | Grant | A | 0.00 | 35,000 | 0 | 123,559 | 88.6 K to 123.6 K (+39.52 %) |
Dec 18 2013 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Payment of Exercise | F | 8.33 | 1,880 | 15,660 | 88,559 | 90.4 K to 88.6 K (-2.08 %) |
Aug 21 2013 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Payment of Exercise | F | 4.95 | 1,410 | 6,980 | 90,439 | 91.8 K to 90.4 K (-1.54 %) |
Feb 19 2013 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Option Exercise | A | 3.84 | 50,000 | 192,000 | 50,000 | |
Feb 19 2013 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Payment of Exercise | F | 3.85 | 1,097 | 4,223 | 91,099 | 92.2 K to 91.1 K (-1.19 %) |
Feb 19 2013 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Grant | A | 0.00 | 30,000 | 0 | 92,196 | 62.2 K to 92.2 K (+48.23 %) |
Dec 18 2012 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Payment of Exercise | F | 3.32 | 1,835 | 6,092 | 60,696 | 62.5 K to 60.7 K (-2.93 %) |
Aug 21 2012 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Payment of Exercise | F | 3.86 | 1,376 | 5,311 | 62,531 | 63.9 K to 62.5 K (-2.15 %) |
Aug 06 2012 | AFFX | AFFYMETRIX INC | Last Andrew J. | EVP and GM, GABU | Buy | P | 4.06 | 10,000 | 40,600 | 63,907 | 53.9 K to 63.9 K (+18.55 %) |
Feb 22 2012 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Payment of Exercise | F | 4.61 | 1,048 | 4,831 | 53,907 | 55 K to 53.9 K (-1.91 %) |
Dec 19 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Payment of Exercise | F | 3.80 | 1,834 | 6,969 | 54,955 | 56.8 K to 55 K (-3.23 %) |
Nov 18 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Option Exercise | A | 4.85 | 60,000 | 291,000 | 60,000 | |
Aug 23 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Payment of Exercise | F | 4.53 | 1,376 | 6,233 | 56,789 | 58.2 K to 56.8 K (-2.37 %) |
Aug 09 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Buy | P | 4.16 | 5,000 | 20,800 | 58,165 | 53.2 K to 58.2 K (+9.40 %) |
Feb 22 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Option Exercise | A | 5.31 | 51,000 | 270,810 | 51,000 | |
Feb 22 2011 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Grant | A | 5.31 | 10,000 | 53,100 | 53,165 | 43.2 K to 53.2 K (+23.17 %) |
Dec 20 2010 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Payment of Exercise | F | 5.08 | 1,835 | 9,322 | 43,165 | 45 K to 43.2 K (-4.08 %) |
Aug 24 2010 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Buy | P | 4.07 | 5,000 | 20,350 | 45,000 | 40 K to 45 K (+12.50 %) |
Aug 24 2010 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Buy | P | 4.06 | 5,000 | 20,300 | 40,000 | 35 K to 40 K (+14.29 %) |
Aug 23 2010 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Option Exercise | A | 4.22 | 70,000 | 295,400 | 70,000 | |
Aug 23 2010 | AFFX | AFFYMETRIX INC | Last Andrew J. | Chief Commercial Of ... | Grant | A | 4.22 | 15,000 | 63,300 | 35,000 | 20 K to 35 K (+75.00 %) |
Page: 1